1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Pneumovax NP-Drug Insights,2014

Pneumovax NP-Drug Insights,2014

  • June 2014
  • -
  • Delve Insight

DelveInsight’s pharmaceuticals report, “Pneumovax NP - Drug Insights, 2014” provides Pneumovax NP marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

Scope
- A review of the Pneumovax NP based on information derived from company and industry-specific sources
- Coverage of the Marketed data of the Pneumovax NP on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Global Forecasted Sales Figure from 2011-2015
- Qualitative and quantitative assessment of market space
- SWOT Analysis

Reasons to buy
- Evaluate the marketing status and exclusivity details of Pneumovax NP to exploit opportunities for generic drug development opportunities.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Pneumovax NP.
- API intelligence over Pneumovax NP and gaining primary intelligence over Active Ingredients manufacturers across the globe.
- Understanding the chemical route of synthesis of Pneumovax NP.
- Uncovering opportunities in the rapidly growing the US market
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Obtain sales forecast for currently marketed drug for 2011-2015

Table Of Contents

Pneumovax NP-Drug Insights,2014
- Drug Overview
- Global Sales Assessment
- Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Marketed Details for the United States
- Marketed Details for the Europe
- Patent Information
- Patent and Exclusivity Expiry Assessment United States (US)
- Patent Numbers and Expiry Details
- Patent Details
- Route of Synthesis
- Global API Manufacturers Assessment
- The United States Drug Master File (US DMF)
- The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
- The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
- The Active Pharmaceutical Ingredient (API) Manufacturers by Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
- Generic Players
- The Pipeline Coverage
- Clinical Trials Information
- Clinical Trials by Zone
- Company Profile
- Summary
- Company Financials
- SWOT Analysis
- References
- Appendix
- Methodology
- About DelveInsight
- Contact Us
- Disclaimer


List of Tables
- Pneumovax NP, Market, Global Sales (in USD), 2014
- Pneumovax NP, Description
- Pneumovax NP, Marketed Details the United States (US)
- Pneumovax NP, Marketed Details the Europe (EU)
- Pneumovax NP, Patent/Exclusivity Expiry (Year), 2014
- Pneumovax NP, Patent Number Specific Patent Expiry (Year), 2014
- Pneumovax NP, Patent Details
- Pneumovax NP, Route of Synthesis
- Pneumovax NP, the United States Drug Master File (US DMF), 2014
- Pneumovax NP, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
- Pneumovax NP, the API Manufacturers, China, 2014
- Pneumovax NP, the API Manufacturers, India, 2014
- Pneumovax NP, the API Manufacturers by the US DMF Status, 2014
- Pneumovax NP, the API Manufacturers by Region, 2014
- Pneumovax NP, the API Manufacturers by Location/Countries, 2014
- Pneumovax NP, Generic Players, 2014
- Pneumovax NP, Pipeline Drug Details, 2014
- Pneumovax NP, Clinical Trials, 2014
- Pneumovax NP, Clinical Trials by Zone, 2014
- Company Overview, 2014
- Pneumovax NP, SWOT Analysis, 2014
- Phase III Pipeline Therapeutics, 2014

List of Figures
- Pneumovax NP, Market, Global Sales (in million USD), 2014
- Pneumovax NP, Global Sales % Change, 2014
- Pneumovax NP, Patent/Exclusivity Expiry (Year), 2014
- Pneumovax NP, Patent Number Specific Patent Expiry (Year), 2014
- Pneumovax NP, Route of synthesis
- Pneumovax NP, the API Manufacturers by the US DMF Status (%), 2014
- Pneumovax NP, the API Manufacturers by Region, 2014
- Pneumovax NP, the API Manufacturers by Location/Countries, 2014
- Pneumovax NP, Generic Players, 2014
- Pneumovax NP, Clinical Trials by Zone (%), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Veterinary vaccines are extensively used in the prevention of life-threatening animal diseases. This report on the global veterinary vaccines market analyzes the current and future prospects of the market. ...

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Human Vaccines Market: Scope and Methodology This report provides in-depth region wise and country wise analysis of the human vaccines market. Stakeholders of this report include manufacturers of human ...


Download Unlimited Documents from Trusted Public Sources

Related Market Segments :

Vaccine

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.